MétaCan
Menu
Back to cohort
Record W4413842901 · doi:10.1002/mds.70026

Brain Atrophy Does Not Predict Clinical Progression in Progressive Supranuclear Palsy

2025· article· en· W4413842901 on OpenAlexfundno aff
Andrea Quattrone, Nicolai Franzmeier, Hans‐Jürgen Huppertz, Nicholas Seneca, Gabor C. Petzold, Annika Spottke, Johannes Levin, Johannes Prudlo, Emrah Düzel

Bibliographic record

VenueMovement Disorders · 2025
Typearticle
Languageen
FieldMedicine
TopicParkinson's Disease Mechanisms and Treatments
Canadian institutionsnot available
FundersNIH Clinical CenterUniversität RostockLeibniz-GemeinschaftUniversitätsklinikum KölnDeutschen Konsortium für Translationale KrebsforschungServierCentre Hospitalier Universitaire de BordeauxUniversität UlmRheinische Friedrich-Wilhelms-Universität BonnHumboldt-Universität zu BerlinLudwig-Maximilians-Universität MünchenUniversidad de NavarraEisaiUniversity of TorontoDeutsches KrebsforschungszentrumKorea UniversityJohns Hopkins UniversityEberhard Karls Universität TübingenUniversity College LondonInstitute for Translational NeuroscienceUniversität zu KölnUniversity of OttawaImperial College LondonDeutsche ForschungsgemeinschaftOchsner HealthTeva Pharmaceutical IndustriesKorea University Guro HospitalRush UniversityVolkswagen FoundationPennsylvania State UniversityTechnische Universität MünchenMinistero della SaluteForschungszentrum JülichBiogenPfizerH. Lundbeck A/SFreie Universität BerlinDeutsches Zentrum für Neurodegenerative ErkrankungenUniversidade de AveiroUniversity of PennsylvaniaSchool of Public Health, Imperial College LondonTechnische Universität DresdenSanofiBayer VitalBristol-Myers Squibb
KeywordsProgressive supranuclear palsyAtrophyMedicineNeurosciencePhysical medicine and rehabilitationDegenerative diseasePsychologyCentral nervous system diseasePathology

Abstract

fetched live from OpenAlex

Abstract Background Clinical progression rate is the typical primary endpoint measure in progressive supranuclear palsy (PSP) clinical trials. Objectives This longitudinal multicohort study investigated whether baseline clinical severity and regional brain atrophy could predict clinical progression in PSP–Richardson's syndrome (PSP‐RS). Methods PSP‐RS patients (n = 309) from the placebo arms of clinical trials (NCT03068468, NCT01110720, NCT02985879, NCT01049399) and DescribePSP cohort were included. We investigated associations of baseline clinical and volumetric magnetic resonance imaging (MRI) data with 1‐year longitudinal PSP rating scale (PSPRS) change. Machine learning (ML) models were tested to predict individual clinical trajectories. Results PSP‐RS patients showed a mean PSPRS score increase of 10.3 points/yr. The frontal lobe volume showed the strongest association with subsequent clinical progression (β: −0.34, P < 0.001). However, ML models did not accurately predict individual progression rates ( R 2 <0.15). Conclusions Baseline clinical severity and brain atrophy could not predict individual clinical progression, suggesting no need for MRI‐based stratification of patients in future PSP trials. © 2025 The Author(s). Movement Disorders published by Wiley Periodicals LLC on behalf of International Parkinson and Movement Disorder Society.

Fetched live from OpenAlex and de-inverted. Abstracts are not stored in this database: the inverted indexes are 8.6 GB of the frame’s 9.3 GB of text, and the host has 13 GB free.

How this classification was reachedexpand

Full frame distilled prediction

Teacher imitation

Not calibrated prevalence, not ground truth. Human validation pending. Learned from the 10,348 direct Codex labels and 10,348 direct Gemma labels. Candidate is the union of thresholded teacher heads; consensus is their intersection. These outputs are machine_predicted_unvalidated and are not human labels or direct frontier model labels.

metaresearch head score (Codex)0.000
metaresearch head score (Gemma)0.000
Version: codex-gemma-dda1882f352aValidation status: machine_predicted_unvalidated
Candidate categoriesnone
Consensus categoriesnone
DomainCandidate signal: none · Consensus signal: none
Study designCandidate signal: Observational · Consensus signal: Observational
GenreCandidate signal: Empirical · Consensus signal: Empirical
Teacher disagreement score0.173
Threshold uncertainty score0.696

Codex and Gemma teacher scores by category

CategoryCodexGemma
Metaresearch0.0000.000
Meta-epidemiology (narrow)0.0000.000
Meta-epidemiology (broad)0.0000.000
Bibliometrics0.0000.000
Science and technology studies0.0000.000
Scholarly communication0.0000.000
Open science0.0000.000
Research integrity0.0000.000
Insufficient payload (model declined to judge)0.0000.000

Machine scores (provisional)

The two teacher heads of the student model, read on this work. A score orders the frame for review; it never asserts a category, and the validation status ships verbatim with every row.

Baseline scores from an immature model (maturity gate not passed, 7 training rounds). Scores rank; they never assert a category.

Opus teacher head0.012
GPT teacher head0.332
Teacher spread0.320 · how far apart the two teachers sit on this one work
Validation statusscore_only:v0-immature-baseline · verbatim from the scoring run: score_only means the number may rank works, and no category label ships from it

Classification

machine, unvalidated

Machine predicted; a candidate call from one teacher head, not a consensus.

The models applied no category: nothing in the taxonomy fit this work.
Study designObservational
Domainnot available
GenreEmpirical

How this classification was reached, model by model and score by score, is at the end of the page under "How this classification was reached".

Quick stats

Citations5
Published2025
Admission routes1
Has abstractyes

Explore more

Same venueMovement DisordersSame topicParkinson's Disease Mechanisms and TreatmentsFrench-language works237,207